IL1B and non-small cell lung carcinoma: IL-1α and IL-1β transcript levels have been evaluated in melanoma, non-small cell carcinoma, colon, and squamous cell cancer cell lines via real-time qRT-PCR, and several of these cell lines exhibit significantly increased levels of IL-1α or IL-1β [18].